Why APOE4 Went from Survival Advantage to Health Risk
In this segment Dr. Jeffrey Gladden explains that the APOE4 allele conferred a historic survival advantage by triggering a stronger inflammatory response to pathogens, which helped early humans survive acute infections. He emphasizes that this benefit was relevant for tens of thousands of years when infectious disease pressure was high. However, in modern environments where such acute threats are reduced, the same heightened inflammation can be maladaptive, accelerating chronic disease processes. The core argument is that APOE4’s value is context‑dependent: it supports short‑term survival against immediate challenges but compromises long‑term health when the challenge shifts, illustrating an evolutionary trade‑off between early‑life fitness and later‑life disease risk.
